The Use of Rifaximin in the Prevention of Overt Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt : A Randomized Controlled Trial.
Christophe BureauDominique ThabutCaroline JezequelIsabelle ArchambeaudLouis D'AlterocheSêbastien DharancyPatrick BorentainFrédéric ObertiAurélie PlessierVictor De LedinghenNathalie Ganne-CarriéNicolas CarbonellVanessa RousseauAgnes SommetJean Marie PéronJean Pierre VinelPublished in: Annals of internal medicine (2021)
French Public Health Ministry.